Generic placeholder image

Epigenetic Diagnosis & Therapy (Discontinued)


ISSN (Print): 2214-0832
ISSN (Online): 2214-0840

DNA Demethylation by TET Proteins: A Potential Therapeutic Target in Cancer

Author(s): Elise A. Mahe and Gilles Salbert

Volume 1, Issue 1, 2015

Page: [49 - 59] Pages: 11

DOI: 10.2174/2214083201666150221002517


DNA methylation in unique genomic regions like enhancers and promoters contributes to cell identity by silencing gene expression. Hence, establishment of cell-specific repertoires of active genes during cell differentiation or in response to extracellular signals may require erasure of this epigenetic mark. By their ability to hydroxylate the methyl group of 5-methylcytosine (5mC), Teneleven translocation (TET) proteins are part of the cellular machinery erasing DNA methylation through molecular mechanisms involving iterative oxidation of 5mC, base excision and repair. Here we review recent discoveries on TET functions and their role in regulating the genome activity to establish and maintain cell identity. We further describe how the TET-mediated processes are affected in cancer cells and propose possible strategies for the correction of these cancer-associated defects.

Keywords: 5-hydroxymethylcytosine, 5hmC, cancer, DNA methylation, TET.

Graphical Abstract

© 2023 Bentham Science Publishers | Privacy Policy